Status:
COMPLETED
Clot Formation and Clot Stability in Patients With Severe Haemophilia A
Lead Sponsor:
University of Aarhus
Conditions:
Hemophilia A
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
In the present study we are examining the clot formation and clot stability in patients with severe haemophilia A after they receive recombinat factor VIII and after addition of tranexamic acid. Our h...
Detailed Description
In the present study we are examining the clot formation and clot stability in patients with severe haemophilia A after they receive recombinat factor VIII and after addition of tranexamic acid. Our h...
Eligibility Criteria
Inclusion
- Severe haemophilia A
- Above 17 years old
- Thrombocyt count above 100 x 109/l within the past two years
Exclusion
- Received recombinant factor VIII with in the past 3 days
- Inhibitor against recombinant factor VIII
- HIV-positive
- Ongoing treatment for hepatitis C
- Known kidney disease
- Allergy against Tranexamic acid
- Not able to give informed consent
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
End Date :
June 1 2006
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT00279578
Start Date
January 1 2006
End Date
June 1 2006
Last Update
November 16 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Biochemistry, Center for Haemophilia and Thrombosis
Aarhus, Denmark, 8200